BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 17307163)

  • 21. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2.
    Gallant MA; Slipetz D; Hamelin E; Rochdi MD; Talbot S; de Brum-Fernandes AJ; Parent JL
    Eur J Pharmacol; 2007 Feb; 557(2-3):115-23. PubMed ID: 17207480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin E2 modulates TNF-alpha-induced MCP-1 synthesis in pancreatic acinar cells in a PKA-dependent manner.
    Sun LK; Reding T; Bain M; Heikenwalder M; Bimmler D; Graf R
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1196-204. PubMed ID: 17916652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction and secretion of the chemokines interleukin-8 and monocyte chemotactic protein-1 in human immature leukemia cell lines.
    Steube KG; Meyer C; Drexler HG
    Mol Cell Biol Res Commun; 2000 Jan; 3(1):60-5. PubMed ID: 10683319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways.
    Hashimoto K; Ichiyama T; Hasegawa M; Hasegawa S; Matsubara T; Furukawa S
    Int Arch Allergy Immunol; 2009; 149(3):275-82. PubMed ID: 19218821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.
    Zayed N; Afif H; Chabane N; Mfuna-Endam L; Benderdour M; Martel-Pelletier J; Pelletier JP; Motiani RK; Trebak M; Duval N; Fahmi H
    Arthritis Rheum; 2008 Nov; 58(11):3530-40. PubMed ID: 18975308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D-type prostanoid receptor enhances the signaling of chemoattractant receptor-homologous molecule expressed on T(H)2 cells.
    Sedej M; Schröder R; Bell K; Platzer W; Vukoja A; Kostenis E; Heinemann A; Waldhoer M
    J Allergy Clin Immunol; 2012 Feb; 129(2):492-500, 500.e1-9. PubMed ID: 21930295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2.
    Hata AN; Lybrand TP; Marnett LJ; Breyer RM
    Mol Pharmacol; 2005 Mar; 67(3):640-7. PubMed ID: 15563582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNF-alpha-induced chemokine production and apoptosis in human neural precursor cells.
    Sheng WS; Hu S; Ni HT; Rowen TN; Lokensgard JR; Peterson PK
    J Leukoc Biol; 2005 Dec; 78(6):1233-41. PubMed ID: 16314440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The opposing role of two prostaglandin D2 receptors, DP and CRTH2, in human eosinophil migration.
    Chiba T; Ueki S; Ito W; Kato H; Kamada R; Takeda M; Kayaba H; Furue M; Chihara J
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):511-7. PubMed ID: 21624751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide- or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8.
    Matsukawa A; Miyazaki S; Maeda T; Tanase S; Feng L; Ohkawara S; Yoshinaga M; Yoshimura T
    Lab Invest; 1998 Aug; 78(8):973-85. PubMed ID: 9714185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
    Cossette C; Walsh SE; Kim S; Lee GJ; Lawson JA; Bellone S; Rokach J; Powell WS
    J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R; Hansel TT
    Drug News Perspect; 2008; 21(6):317-22. PubMed ID: 18836589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways.
    Faveeuw C; Gosset P; Bureau F; Angeli V; Hirai H; Maruyama T; Narumiya S; Capron M; Trottein F
    Eur J Immunol; 2003 Apr; 33(4):889-98. PubMed ID: 12672054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implication of S-adenosylhomocysteine hydrolase in inhibition of TNF-alpha- and IL-1beta-induced expression of inflammatory mediators by AICAR in RPE cells.
    Qin S; Ni M; De Vries GW
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1274-81. PubMed ID: 18326758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.
    LappegÄrd KT; Fung M; Bergseth G; Riesenfeld J; Mollnes TE
    Ann Thorac Surg; 2004 Jul; 78(1):38-44; discussion 44-5. PubMed ID: 15223398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostanoid DP receptor antagonists suppress symptomatic asthma-like manifestation by distinct actions from a glucocorticoid in rats.
    Hirano Y; Shichijo M; Ikeda M; Kitaura M; Tsuchida J; Asanuma F; Yanagimoto T; Furue Y; Imura K; Yasui K; Arimura A
    Eur J Pharmacol; 2011 Sep; 666(1-3):233-41. PubMed ID: 21596028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
    Monneret G; Cossette C; Gravel S; Rokach J; Powell WS
    J Pharmacol Exp Ther; 2003 Jan; 304(1):349-55. PubMed ID: 12490611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of indole derivatives exclusively interfering with a G protein-independent signaling pathway of the prostaglandin D2 receptor CRTH2.
    Mathiesen JM; Ulven T; Martini L; Gerlach LO; Heinemann A; Kostenis E
    Mol Pharmacol; 2005 Aug; 68(2):393-402. PubMed ID: 15870392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRTH2 and D-type prostanoid receptor antagonists as novel therapeutic agents for inflammatory diseases.
    Schuligoi R; Sturm E; Luschnig P; Konya V; Philipose S; Sedej M; Waldhoer M; Peskar BA; Heinemann A
    Pharmacology; 2010; 85(6):372-82. PubMed ID: 20559016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.